The data further support the hypothesis of a causal genetic-epigenetic-transcriptional interplay within the extended 1q21.1 locus, with functional evidence of contribution from CHD1L in progressive MS pathology, possibly via a detrimental effect on axonal and dendritic projections and neuronal activity. The gene discussed is CHD1L; the disease is myeloid sarcoma.